Alpha Tau Medical (DRTS) vs LeMaitre Vascular (LMAT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Alpha Tau Medical (DRTS) has outperformed LeMaitre Vascular (LMAT) over the past year, gaining 235.7% versus a loss of 9.5%. Over five years, LMAT leads with a +48.6% price change compared with +41.6% for DRTS. LeMaitre Vascular is the larger company by market cap ($1.82 billion vs $1.29 billion), about 1.4 times the size.
LeMaitre Vascular pays a dividend yielding 1.13%, while Alpha Tau Medical does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | DRTS | LMAT |
|---|---|---|
| Share price | $14.00 | $79.64 |
| Market cap | $1.29B | $1.82B |
| 1-day change | -1.75% | +0.42% |
| YTD return | +182.83% | -1.80% |
| 1-year return | +235.73% | -9.54% |
| 5-year return | +41.56% | +48.64% |
| P/E ratio (TTM) | — | 27.94 |
| Forward P/E | — | 25.05 |
| EPS (TTM) | $-1.04 | $2.85 |
| Dividend yield | 0.00% | 1.13% |
| Annual dividend | $0.00 | $0.90 |
| Revenue (latest FY) | — | $249.60M |
| Revenue growth (YoY) | — | +13.53% |
| Net income (latest FY) | — | $57.73M |
| Gross margin | — | 71.53% |
| Operating margin | — | 27.21% |
| Net margin | — | 23.13% |
| 52-week high | $15.79 | $118.01 |
| 52-week low | $3.43 | $78.22 |
| Distance from 52-week high | -11.34% | -32.51% |
| Analyst consensus | none | buy |
| Avg. price target upside | +27.14% | +34.35% |
| Average volume | 569.88K | 330.14K |
| Shares outstanding | 92.48M | 22.87M |
| Employees | 121 | 646 |
| Sector | Health Care | Healthcare |
| Industry | Medical/Dental Instruments | Medical Instruments & Supplies |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- DRTS has outperformed LMAT by 245.3 percentage points over the past year.
- LeMaitre Vascular offers a meaningfully higher dividend yield (1.13% vs 0.00%).
- The two companies sit in different sectors: Alpha Tau Medical in Health Care and LeMaitre Vascular in Healthcare.
About Alpha Tau Medical
DRTS stock →Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors.
Health Care · Medical/Dental Instruments · 121 employees
About LeMaitre Vascular
LMAT stock →LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery in the Americas, Europe, the Middle Esat, Africa, and the Asia Pacific.
Healthcare · Medical Instruments & Supplies · 646 employees
DRTS vs LMAT FAQ
Which is bigger, Alpha Tau Medical or LeMaitre Vascular?
LeMaitre Vascular (LMAT) is larger, with a market capitalization of $1.82B compared with $1.29B for Alpha Tau Medical (DRTS).
Which stock has performed better over the past year, DRTS or LMAT?
DRTS returned +235.73% over the past 12 months, compared with -9.54% for LMAT (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Alpha Tau Medical or LeMaitre Vascular?
LeMaitre Vascular pays a dividend yielding 1.13%, while Alpha Tau Medical does not currently pay a regular dividend.
Are Alpha Tau Medical and LeMaitre Vascular in the same industry?
No. Alpha Tau Medical is in the Health Care sector, while LeMaitre Vascular is in Healthcare.